Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: QVAR 80

« Back to Dashboard
Qvar 80 is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from three suppliers. There are three patents protecting this drug.

This drug has forty-nine patent family members in eighteen countries.

The generic ingredient in QVAR 80 is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.

Summary for Tradename: QVAR 80

Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list14

Pharmacology for Tradename: QVAR 80

Clinical Trials for: QVAR 80

Effect of Inhaled Steroids on Gene Expression in the Lungs - 2
Status: Active, not recruiting Condition: Chronic Obstructive Pulmonary Disease (COPD)

Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth
Status: Recruiting Condition: Asthma

Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)
Status: Completed Condition: Asthma

Effect of Steroids on Gene Expression in the Healthy Smokers Lungs
Status: Terminated Condition: Chronic Obstructive Pulmonary Disease (COPD)

Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications
Status: Completed Condition: Asthma; Obesity

A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
Status: Completed Condition: Persistent Asthma

Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis
Status: Recruiting Condition: Asthma; Allergic Rhinitis

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 5-11 Years Old With Persistent Asthma
Status: Recruiting Condition: Asthma

Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)
Status: Withdrawn Condition: Asthma

Randomized Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal GVHD
Status: Completed Condition: Graft Vs Host Disease; Gastrointestinal Graft-Versus-Host Disease

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm
QVAR 80
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-001Sep 15, 2000RXYes5,776,432<disabled>Y<disabled>
Teva Branded Pharm
QVAR 80
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-001Sep 15, 2000RXYes6,446,627<disabled>Y<disabled>
Teva Branded Pharm
QVAR 80
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-001Sep 15, 2000RXYes5,683,677<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: QVAR 80

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,681,545 Medicinal aerosol formulations<disabled in preview>
6,346,232 Method of forming conductive lines<disabled in preview>
5,766,573 Medicinal aerosol formulations<disabled in preview>
5,776,434 Medicinal aerosol formulations<disabled in preview>
5,720,940 Medicinal aerosol formulations<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: QVAR 80

Country Document Number Publication Date
Germany69729485Jul 15, 2004
Denmark595789Nov 27, 1989
Mexico9203481Jul 01, 1992
European Patent Office0653204Nov 15, 1995
Spain2077971Dec 17, 2009
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc